SomnoMed Overview

  • Founded
  • 1987
Founded
  • Status
  • Public
  • Employees
  • 300
Employees
  • Stock Symbol
  • SOM
Stock Symbol
  • Investments
  • 6
  • Share Price
  • $0.96
  • (As of Friday Closing)

SomnoMed General Information

Description

SomnoMed Ltd produces and sells oral treatment of sleep related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep disordered breathing relieving conditions. Its products include SomnoDent oral appliance for obstructive sleep apnea; and SomnoBrux, a mouthguard, which protects patients from teeth grinding damage, as well as SomTabs for cleaning its devices.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Therapeutic Devices
Stock Exchange
ASX
Primary Office
  • Level 3 20 Clarke Street
  • Crows Nest
  • Sydney, New South Wales 2065
  • Australia
+61 0000000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SomnoMed Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.96 $0.94 $0.54 - $1.97 $75.1M 78.4M 49.4K

SomnoMed Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 54,580 54,580 58,829 88,125
Revenue 42,109 49,273
EBITDA 1,597 (5,744)
Net Income (11,753) (6,677)
Total Assets 24,337 33,569
Total Debt 2,518 1,054
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SomnoMed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SomnoMed‘s full profile, request access.

Request a free trial

SomnoMed Executive Team (4)

Name Title Board Seat Contact Info
Peter Neustadt Chief Executive Officer & Chairman
Derek Smith Global Chief Executive Officer
Neil Verdal-Austin Chief Financial Officer
To view SomnoMed’s complete executive team members history, request access »

SomnoMed Board Members (1)

Name Representing Role Since
00000 00000000 SomnoMed Chief Executive Officer & Chairman 000 0000
To view SomnoMed’s complete board members history, request access »

SomnoMed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SomnoMed Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SomnoMed‘s full profile, request access.

Request a free trial

SomnoMed Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 0000 03-Nov-2015 000000000000000000 00000 Diagnostic Equipment 00000 00000000
000 00000000000 31-Jul-2015 000000000000000000 00000 Other Devices and Supplies 00000 00000000
000000000 14-Dec-2012 000000000000000000 00000 Diagnostic Equipment
00000000 09-Oct-2012 000000000000000000 00000 Other Devices and Supplies
SomnoMed Goedegebuure Slaaptechniek 31-Mar-2012 Merger/Acquisition 00.000 Therapeutic Devices
You’re viewing 5 of 6 acquisitions. Get the full list »

SomnoMed Subsidiaries (1)

Company Name Industry Location Founded
00000000 000000000 Therapeutic Devices Loenen, Netherlands 0000
To view SomnoMed’s complete subsidiaries history, request access »